Trial intelligence / Profile preview

Shuangteng Qinglin tablets in non-gonococcal urethritis/cervicitis (TCM damp-heat pattern)

CTR20132719Phase 2Suspended

Sponsor
Guangzhou Ouhua Pharmaceutical Biotechnology
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Shuangteng Qinglin Pian in nongonococcal urethritis (NGU), cervicitis, sponsored by Guangzhou Ouhua Pharmaceutical Biotechnology. Started Apr 2014; status: suspended.

02

Drugs

Shuangteng Qinglin Pian
03

Conditions

nongonococcal urethritis (NGU)cervicitis

Beyond the preview

Go deeper on CTR20132719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call